<DOC>
	<DOCNO>NCT01715805</DOCNO>
	<brief_summary>The objective study evaluate efficacy , safety tolerability cariprazine adjunctive treatment antidepressant therapy ( ADT ) patient MDD</brief_summary>
	<brief_title>An Efficacy , Safety Tolerability Cariprazine Adjunctive Treatment Antidepressant Therapy ( ADT ) Patients With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Patients provide consent prior specific procedure Meet The Diagnostic Statistical Manual Mental Disorders , 4th edition , text revision ( DSMIVTR ) criteria Major Depressive Disorder ( MDD ) Have minimum score 20 17Item Hamilton Depression ( HAMD17 ) rating scale Visits 1 2 Patients meet DSMIVTR criterion MDD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>MDD</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>